Novavax's COVID vaccine could soon be available in the US
A fourth COVID-19 vaccine option, made by Novavax, could soon be available in the U.S. after FDA advisers recommended its authorization.
Stay updated with breaking news from Prevention Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A fourth COVID-19 vaccine option, made by Novavax, could soon be available in the U.S. after FDA advisers recommended its authorization.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
/PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and...
The PPD clinical research business of Thermo Fisher Scientific and Moderna, whose pioneering mRNA vaccine for COVID has been administered to hundreds of millions globally, were named "Clinical Research Team of the Year" during the 2021 Citeline Awards. As Moderna's clinical research organization partner, the PPD ...